The article cited AMA's Global Genomics Market Study explored substantial growth with CAGR of 14.2%. According to the study, Growing R&D in the field of Genomics, and the Lower Cost of Deoxyribonucleic Acid Amplification using PCR is one of the primary growth factors for the market. Rising Government Funding and Growth in the Number of Genomics Projects is also expected to contribute significantly to the Genomics market. Overall, Drug Discovery and Development applications of Genomics, and the growing awareness of them, is what makes this segment of the industry important to its overall growth. The presence of players such as Thermo Fisher Scientific, Inc. (United States), Illumina, Inc. (United States), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (United States), Eurofins Scientific (Germany), BGI Genomics (China), GE Healthcare (United States), Bio-Rad Laboratories, Inc. (United States), F. Hoffmann-La Roche Ltd. (Switzerland), Pacific Biosciences of California, Inc. (United States) and Myriad Genetics (United States) pushing strong cash flow in Market which is also a key in driving revenue growth.

AMA’s Analyst on the Global Genomics market identified that the demand is rising in many different parts of the world as "Increasing Use of Genomics in Specialized/Personalized Medicine across the World". One of the challenges that industry facing is "Problem Regarding Secure Storage of Large Volumes of Sequenced Data as well as Dearth of Trained Professionals"

The report provides an in-depth analysis and forecast about the industry covering the following key features:

• Detailed Overview of Genomics market will help deliver clients and businesses making strategies.
• Influencing factors that thriving demand and latest trend running in the market
• What is the market concentration? Is it fragmented or highly concentrated?
• What trends, challenges and barriers will impact the development and sizing of Genomics market
• SWOT Analysis of profiled players and Porter's five forces & PEST Analysis for deep insights.
• What growth momentum or downgrade market may carry during the forecast period?
• Which region may tap highest market share in coming era?
• What focused approach and constraints are holding the Genomics market tight?
• Which application/end-user category or Product Type [] may seek incremental growth prospects?
• What would be the market share of key countries like Germany, USA, France, China etc.?

Market Size Estimation
In market engineering method, both top-down and bottom-up approaches have been used, along with various data triangulation process, to predict and validate the market size of the Genomics market and other related sub-markets covered in the study.

o Key & emerging players in the Genomics market have been observed through secondary research.
o The industry’s supply chain and overall market size, in terms of value, have been derived through primary and secondary research processes.
o All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Data Triangulation
The overall Genomics market size is calculated using market estimation process, the Genomics market was further split into various segments and sub-segments. To complete the overall market engineering and arriving at the exact statistics for all segments and sub-segments, the market breakdown and data triangulation procedures have been utilized, wherever applicable. The data have been triangulated by studying various influencing factors and trends identified from both demand and supply sides of various applications involved in the study. Along with this, the Global Genomics market size has been validated using both top-down and bottom-up approaches.